"Global Hepatocellular Carcinoma Drugs Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 Hepatocellular Carcinoma Drugs Market Set for Significant Growth Amid Rising Industry Demand, New...